The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Open accessAbstract
The development of cancer is driven by the accumulation of scores of alterations affecting the structure and function of the genome. Equally important in this process are genetic alterations and epigenetic changes. Whereas the former disrupt normal patterns of gene expression, sometimes leading to the expression of abnormal, constitutively active proteins, the latter deregulate the mechanisms such as transcriptional control leading to the inappropriate silencing or activation of cancer‐associated genes. Both types of changes are inheritable at the cellular level, thus contributing to the clonal expansion of cancer cells. In this review, we summarize current knowledge on how genetic alterations in oncogenes or tumour suppressor genes, as well as epigenetic changes, can be exploited in the clinics as biomarkers for cancer detection, diagnosis and prognosis. We propose a rationale for identifying alterations that may have a functional impact within a background of “passenger” alterations that may occur solely as the consequence of deregulated genetic and epigenetic stability. Such functional alterations may represent candidates for targeted therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Prósper, F., Heiniger, A., & Torres, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4944 · Cited by 128
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527 · cited 1×
“…considerable interest due to their potential clinical significance in predicting the response of lung cancer patients to small molecule Tyrosine Kinase Inhibitors (TKIs) such as erlotinib or gefinitib (Paez et al., 2004; Pao et al., 2004, 2005; Shigematsu and Gazdar, 2006; Toyooka et al., 2005).”
BackgroundThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis
Surani, M. A. H., Barton, S. C., & Norris, M. L. (1984) · Nature · doi:10.1038/308548a0 · Cited by 1,430
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Polycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 2×
“…is accompanied by specific histone modifications that are typical of heterochromatin, and that abnormal epigenetic premarking during early embryonic development may predispose certain genes to cancer promoting DNA methylation events (Schlesinger et al., 2006; Widschwendter et al., 2006).”
BackgroundEpigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
microRNAs exhibit high frequency genomic alterations in human cancer
Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,031
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 2×
“The protein product of p16 gene has long been recognized as a tumour suppressor and mediator of cell senescence (Gil and Peters, 2006).”
BackgroundLoss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
Kambara, T., Simms, L. A., Whitehall, V. L. J., Spring, K. J., Wynter, C. V. A., Walsh, M. D., Barker, M. A., Arnold, S., McGivern, A., Matsubara, N., et al. (2004) · Gut · doi:10.1136/gut.2003.037671 · Cited by 722
Takano, T., Ohe, Y., Sakamoto, H., Tsuta, K., Matsuno, Y., Tateishi, U., Yamamoto, S., Nokihara, H., Yamamoto, N., Sekine, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.0793 · Cited by 695
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
Shigematsu, H., & Gazdar, A. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21496 · Cited by 657
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
The histone H4 acetyltransferase MOF uses a C 2 HC zinc finger for substrate recognition
Akhtar, A., & Becker, P. B. (2001) · EMBO reports · doi:10.1093/embo-reports/kve022 · Cited by 632
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Olivier, M., Langer√∏d, A., Carrieri, P., Bergh, J., Klaar, S., Eyfjord, J., Theillet, C., Rodriguez, C., Lidereau, R., Bi√®che, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1029 · Cited by 589
Self-citationMutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Samowitz, W. S., Albertsen, H., Herrick, J., Levin, T. R., Sweeney, C., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.020 · Cited by 577
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation
Pray-Grant, M. G., Daniel, J. A., Schieltz, D., Yates, J. R., & Grant, P. A. (2005) · Nature · doi:10.1038/nature03242 · Cited by 515
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases
Yang, X.-J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh252 · Cited by 515
Šulić, S., Panić, L., Barkić, M., Merćep, M., Uzelac, M., & Volarević, S. (2005) · Genes & Development · doi:10.1101/gad.359305 · Cited by 510
Epigenetic patterns in the progression of esophageal adenocarcinoma.
Eads, C. A., Lord, R. V., Wickramasinghe, K. S., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., et al. (2001) · PubMed · Cited by 500
Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Möslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., et al. (1996) · PubMed · Cited by 466
Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., & Feinberg, A. P. (1994) · Nature Genetics · doi:10.1038/ng0794-433 · Cited by 460
Gormally, E., Caboux, E., Vineis, P., & Hainaut, P. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.11.002 · Cited by 445
Self-citation(2002) · PubMed · Cited by 440
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397
Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Danenberg, P. V., & Laird, P. W. (1999) · PubMed · Cited by 393
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
Kawakami, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 376
DNA methylation and imprinting: why bother?
Jaenisch, R. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01180-3 · Cited by 364
Human cancers express a mutator phenotype
Bielas, J. H., Loeb, K. R., Rubin, B. P., True, L. D., & Loeb, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607057103 · Cited by 354
Molecular mechanisms of E2F-dependent activation and pRB-mediated repression
Frolov, M. V., & Dyson, N. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01227 · Cited by 338
Chromatin modifier enzymes, the histone code and cancer
Santos-Rosa, H., & Caldas, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.010 · Cited by 337
Forbes, S., Clements, J., Dawson, E., Bamford, S., Webb, T., Dogan, A., Flanagan, A., Teague, J., Wooster, R., Futreal, P. A., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602928 · Cited by 331
Esteller, M., & Herman, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207316 · Cited by 326
Pasquinelli, A. E., Hunter, S., & Bracht, J. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.01.002 · Cited by 325
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
Müller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., Marth, C., & Widschwendter, M. (2003) · PubMed · Cited by 317
Epigenetic lesions at the H19 locus in Wilms' tumour patients
Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., et al. (1994) · Nature Genetics · doi:10.1038/ng0794-440 · Cited by 316
Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., & Herman, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12754 · Cited by 314
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Goel, A., Nagasaka, T., Arnold, C. N., Inoue, T., Hamilton, C., Niedzwiecki, D., Compton, C., Mayer, R. J., Goldberg, R., Bertagnolli, M. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.09.018 · Cited by 300
Association between CpG island methylation and microsatellite instability in colorectal cancer.
Ahuja, N., MOHAN, A. L., Li, Q., Stolker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., & Issa, J. J. (1997) · PubMed · Cited by 295
Esteller, M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.26 · Cited by 293
Lecomte, T., Berger, A., Zinzindohoué, F., Micard, S., Landi, B., Blons, H., Beaune, P., Cugnenc, P., & Laurent‐Puig, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10526 · Cited by 292
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
Cellular machineries for chromosomal DNA repair
Peterson, C. L., & Côté, J. (2004) · Genes & Development · doi:10.1101/gad.1182704 · Cited by 285
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., & Feinberg, A. P. (1998) · Nature Medicine · doi:10.1038/3260 · Cited by 284
Chan, M. W. Y., Chan, L. W., Tang, N. L. S., TONG, J. H. M., Lo, K. W., Lee, T., Cheung, H. Y., Wong, W. S., Chan, P. S. F., Lai, F. M., et al. (2002) · PubMed · Cited by 282
Genome-wide prediction of imprinted murine genes
Luedi, P. P., Hartemink, A. J., & Jirtle, R. L. (2005) · Genome Research · doi:10.1101/gr.3303505 · Cited by 259
GRADY, W., RAIPUT, A., LUTTERBAUGH, J., & MARKOWITZ, S. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81443-8 · Cited by 224
Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk
Belinsky, S. A., Klinge, D. M., Dekker, J. D., Smith, M. W., Bocklage, T. J., Gilliland, F. D., Crowell, R. E., Karp, D. D., Stidley, C. A., & Picchi, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0625 · Cited by 215
CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas
Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2005) · Cancer Research · doi:10.1158/0008-5472.828.65.3 · Cited by 211
Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer
Jernimo, C., Usadel, H., Henrique, R., Silva, C., Oliveira, J., Lopes, C., & Sidransky, D. (2002) · Urology · doi:10.1016/s0090-4295(02)01949-0 · Cited by 201
Slattery, M. L., Curtin, K., Sweeney, C., Levin, T. R., Potter, J., Wolff, R. K., Albertsen, H., & Samowitz, W. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22342 · Cited by 196
Identification of silencing of nine genes in human gastric cancers.
Kaneda, A., Kaminishi, M., Yanagihara, K., Sügimura, T., & Ushijima, T. (2002) · PubMed · Cited by 196
Ward, R. L., Cheong, K., Ku, S.-L., Meagher, A., O’Connor, T., & Hawkins, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.123 · Cited by 193
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000) · PubMed · Cited by 190
Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel
Dulaimi, E., Uzzo, R. G., Greenberg, R. E., Al-Saleem, T., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0127 · Cited by 188
Lee, T., Leung, W. K., Chan, M. W. Y., Ng, E. K., TONG, J. H. M., Lo, K. W., Chung, S. C. S., Sung, J. J. �., & To, K. (2002) · PubMed · Cited by 186
An, C., Choi, I.-S., Yao, J. C., Worah, S., Xie, K., Mansfield, P. F., Ajani, J. A., Rashid, A., Hamilton, S. R., & Wu, T.-T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.656.11.2 · Cited by 183
Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou, H., Yu, B.-M., Wang, Z., Sun, J., Cang, H., Gao, F., Li, D. H., Zhao, R., Feng, G.-G., & Yi, J. (2002) · PubMed · Cited by 179
Ravenel, J. D., Broman, K. W., Perlman, E. J., Niemitz, E. L., Jayawardena, T. M., Bell, D. W., Haber, D. A., Uejima, H., & Feinberg, A. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1698 · Cited by 172
Gormally, E., Vineis, P., Matullo, G., Veglia, F., Caboux, E., Le Roux, E., Peluso, M., Garte, S., Guarrera, S., Munnia, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4556 · Cited by 164
Self-citationCpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan, P. S., Perry, M. R., Laux, D. E., Asare, A. L., Caldwell, C. W., & Huang, T. H. ‐. (2000) · PubMed · Cited by 161
MutS homologs in mammalian cells
Fishel, R., & Wilson, T. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80117-7 · Cited by 161
Genetic alteration and gene expression modulation during cancer progression.
Garnis, C., Buys, T. P. H., & Lam, W. L. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-9 · Cited by 146
Bearzatto, A., Conte, D., Frattini, M., Zaffaroni, N., Andriani, F., Balestra, D., Tavecchio, L., Daidone, M. G., & Sozzi, G. (2002) · PubMed · Cited by 144
Tada, Y., Wada, M., Taguchi, K., Mochida, Y., Kinugawa, N., Tsuneyoshi, M., Naito, S., & Kuwano, M. (2002) · PubMed · Cited by 143
Hypermethylation of the GATA Genes in Lung Cancer
Guo, M., Akiyama, Y., House, M. G., Hooker, C. M., Heath, E., Gabrielson, E. W., Yang, S. C., Han, Y. K., Baylin, S. B., Herman, J. G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1140 · Cited by 130
Chromatin remodeling: why it is important in cancer
Wolffe, A. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204322 · Cited by 127
Multistep tumorigenesis and the microenvironment
Schedin, P. S., & ELIAS, A. D. (2004) · Breast Cancer Research · doi:10.1186/bcr772 · Cited by 126
Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System
Safar, A. M., Spencer, H. J., Su, X., Coffey, M., Cooney, C. A., Ratnasinghe, L. D., Hutchins, L. F., & Fan, C. Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2378 · Cited by 124
Fackler, M. J., Malone, K., Zhang, Z., Schilling, E., Garrett-Mayer, E. S., Swift‐Scanlan, T., Lange, J. R., Nayar, R., Davidson, N. E., Khan, S. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2733 · Cited by 122
Marsit, C. J., McClean, M. D., Furniss, C. S., & Kelsey, K. T. (2006) · International Journal of Cancer · doi:10.1002/ijc.22051 · Cited by 120
EGFRMutation and Response of Lung Cancer to Gefitinib
Toyooka, S., Kiura, K., & Mitsudomi, T. (2005) · New England Journal of Medicine · doi:10.1056/nejm200505193522019 · Cited by 119
Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma
Wong, T., Kwong, D. L., Sham, J. S. T., Wei, W., Kwong, Y., & Yuen, A. P. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0139 · Cited by 118
Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast Cancer
Papadopoulou, E., Davilas, E., Sotiriou, V., Georgakopoulos, E., Georgakopoulou, S., Koliopanos, A., Aggelakis, F., Dardoufas, K., Agnanti, N., Karydas, I., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.032 · Cited by 117
Domínguez, G., Carballido, J., Silva, J., Silva, J. M., García, J. M., Menéndez, J., Provencio, M., España, P., & Bonilla, F. (2002) · PubMed · Cited by 114
DNA Methylation Differences Associated with Tumor Tissues Identified by Genome Scanning Analysis
Liang, G., Salem, C. E., Yu, M. C., Nguyen, H. D., Gonzales, F. A., Nguyen, T. T., Nichols, P. W., & Jones, P. A. (1998) · Genomics · doi:10.1006/geno.1998.5502 · Cited by 114
Pulling, L. C., Vuillemenot, B. R., Hutt, J. A., Devereux, T. R., & Belinsky, S. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2119 · Cited by 112
Wong, T., Man, M. W.-L., Lam, A. K.-Y., Wei, W., Kwong, Y., & Yuen, A. P. W. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00428-3 · Cited by 111
The genetics of HNPCC: Application to diagnosis and screening
Abdel‐Rahman, W. M., Mecklin, J., & Peltomäki, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.11.001 · Cited by 108
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients
An, Q., Liu, Y., Gao, Y., Huang, J., Fong, X., Li, L., Zhang, D.-C., & Cheng, S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00496-2 · Cited by 106
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
Jackson, P. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg101 · Cited by 105
DNA Alterations in Body Fluids as Molecular Tumor Markers for Urological Malignancies
Goessl, C. D., Müller, M., Straub, B., & Miller, K. (2002) · European Urology · doi:10.1016/s0302-2838(02)00126-4 · Cited by 103
Multiple Genetic Alterations in Human Carcinogenesis
Sugimura, T., Terada, M., Yokota, J., Hirohashi, S., & Wakabayashi, K. (1992) · Environmental Health Perspectives · doi:10.1289/ehp.92985 · Cited by 102
Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients
Nakayama, H., Hibi, K., Taguchi, M., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00839-4 · Cited by 101
CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer
Huang, T. H. ‐., Yan, P. S., Perry, M. R., & Laux, D. E. (1999) · Nature Genetics · doi:10.1038/14328 · Cited by 100
Shen, L., Kondo, Y., Hamilton, S. R., Rashid, A., & Issa, J. J. (2003) · Gastroenterology · doi:10.1053/gast.2003.50102 · Cited by 98
An investigation of mutation as a function of age in humans
King, C. M., Gillespie, E. S., McKenna, P. G., & Barnett, Y. (1994) · Mutation Research/DNAging · doi:10.1016/0921-8734(94)90010-8 · Cited by 87
Zhang, Y., Rössner, P., Chen, Y., Agrawal, M., Wang, Q., Wang, L., Ahsan, H., Yu, M., Lee, P., & Santella, R. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21699 · Cited by 83
Assessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
Valenzuela, M., Galisteo, R., Zuluaga, A., Villalobos, M., Núñez, M. I., Oliver, F. J., & de Almodóvar, J. M. R. (2002) · European Urology · doi:10.1016/s0302-2838(02)00468-2 · Cited by 82
Wong, T., Chang, H. W., Tang, K. C., Wei, W., Kwong, D. L. �., Sham, J. S. T., Yuen, A. P. W., & Kwong, Y. (2002) · PubMed · Cited by 82
Tumor suppressor p53 represses transcription of RECQ4 helicase
Sengupta, S., Shimamoto, A., Koshiji, M., Pedeux, R., Rusin, M., Spillare, E. A., Shen, J., Huang, E. L., Lindor, N. M., Furuichi, Y., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208380 · Cited by 81
Woodson, K. G., Flood, A. P., Green, L. D., Tangrea, J. A., Hanson, J., Cash, B. D., Schatzkin, A. G., & Schoenfeld, P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh042 · Cited by 78
Emerging roles for chromatin remodeling in cancer biology
Cairns, B. R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02125-0 · Cited by 73
Balko, J. M., Potti, A., Saunders, C. P., Stromberg, A. J., Haura, E. B., & Black, E. P. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-289 · Cited by 70
Epigenetic Information in Chromatin: the Code of Entry for DNA Repair
Loizou, J. I., Murr, R., Finkbeiner, M. G., Sawan, C., Wang, Z., & Herceg, Z. (2006) · Cell Cycle · doi:10.4161/cc.5.7.2616 · Cited by 67
Self-citationGenomic Imprinting, Mammalian Evolution, and the Mystery of Egg-Laying Mammals
John, R. M., & Surani, M. A. (2000) · Cell · doi:10.1016/s0092-8674(00)80870-3 · Cited by 63
Emerging roles for chromatin remodeling in cancer biology
Cairns, B. R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82074-2 · Cited by 61
Hypermethylation of p16INK4a and p15INK4b genes in non-small cell lung cancer
Kurakawa, E., Shimamoto, T., Utsumi, K., et al. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.277 · Cited by 58
Methylation and prognosis: of molecular clocks and hypermethylator phenotypes.
Issa, J. J. (2003) · PubMed · Cited by 53
Cell-Free DNA and RNA in Plasma as a New Molecular Marker for Prostate Cancer
Papadopoulou, E., Davilas, E., Sotiriou, V., Koliopanos, A., Aggelakis, F., Dardoufas, K., Agnanti, N., Karydas, I., & Nasioulas, G. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040041791473 · Cited by 51
Bazan, V., Bruno, L., Augello, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl958 · Cited by 47
Shigeno, K., Yoshida, H., Pan, L., Luo, J. M., Fujisawa, S., Naito, K., Nakamura, S., Shinjo, K., Takeshita, A., Ohno, R., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00442-7 · Cited by 41
Imprinted genes: identification by chromosome rearrangements and post-genomic strategies
Oakey, R. J., & BEECHEY, C. V. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02708-7 · Cited by 35
Cited by
Patel, K. N., Angell, T. E., Babiarz, J., Barth, N. M., Blevins, T., Duh, Q.-Y., Ghossein, R. A., Harrell, R. M., Huang, J., Kennedy, G. C., et al. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1153 · Cited by 393
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Elazezy, M., & Joosse, S. A. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.002 · Cited by 370
DNA Methylation Biomarkers: Cancer and Beyond
Mikeska, T., & Craig, J. (2014) · Genes · doi:10.3390/genes5030821 · Cited by 288
Genetic etiology of oral cancer
Ali, J., Sabiha, B., Jan, H. U., Haider, S. A., Khan, A. A., & Ali, S. S. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.05.004 · Cited by 256
Postel, M., Roosen, A., Laurent-Puig, P., Taly, V., & Wang-Renault, S.-F. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 254
Metadata
- Authors
- Herceg, Z., & Hainaut, P.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2007-03-14
- Volume
- 1
- Issue
- 1
- Pages
- 26-41
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2086927107
- Cited by
- 282
- References
- 152
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.